Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 5
1993 1
1994 1
1995 6
1996 5
1997 6
1998 6
1999 4
2000 8
2001 4
2002 9
2003 7
2004 9
2005 4
2006 5
2007 4
2008 2
2009 3
2010 4
2011 4
2012 10
2013 9
2014 9
2015 8
2016 3
2017 5
2018 6
2019 7
2020 7
2021 9
2022 11
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

173 results
Results by year
Filters applied: . Clear all
Page 1
Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab.
Capone M, Giannarelli D, Mallardo D, Madonna G, Festino L, Grimaldi AM, Vanella V, Simeone E, Paone M, Palmieri G, Cavalcanti E, Caracò C, Ascierto PA. Capone M, et al. Among authors: caraco c. J Immunother Cancer. 2018 Jul 16;6(1):74. doi: 10.1186/s40425-018-0383-1. J Immunother Cancer. 2018. PMID: 30012216 Free PMC article.
Imaging Assessment of Interval Metastasis from Melanoma.
Simonetti I, Trovato P, Granata V, Picone C, Fusco R, Setola SV, Mattace Raso M, Caracò C, Ascierto PA, Sandomenico F, Petrillo A. Simonetti I, et al. Among authors: caraco c. J Pers Med. 2022 Jun 24;12(7):1033. doi: 10.3390/jpm12071033. J Pers Med. 2022. PMID: 35887530 Free PMC article. Review.
Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma: A Randomized Clinical Trial.
Multicenter Selective Lymphadenectomy Trials Study Group; Crystal JS, Thompson JF, Hyngstrom J, Caracò C, Zager JS, Jahkola T, Bowles TL, Pennacchioli E, Beitsch PD, Hoekstra HJ, Moncrieff M, Ingvar C, van Akkooi A, Sabel MS, Levine EA, Agnese D, Henderson M, Dummer R, Neves RI, Rossi CR, Kane JM 3rd, Trocha S, Wright F, Byrd DR, Matter M, Hsueh EC, MacKenzie-Ross A, Kelley M, Terheyden P, Huston TL, Wayne JD, Neuman H, Smithers BM, Ariyan CE, Desai D, Gershenwald JE, Schneebaum S, Gesierich A, Jacobs LK, Lewis JM, McMasters KM, O'Donoghue C, van der Westhuizen A, Sardi A, Barth R, Barone R, McKinnon JG, Slingluff CL, Farma JM, Schultz E, Scheri RP, Vidal-Sicart S, Molina M, Testori AAE, Foshag LJ, Van Kreuningen L, Wang HJ, Sim MS, Scolyer RA, Elashoff DE, Cochran AJ, Faries MB. Multicenter Selective Lymphadenectomy Trials Study Group, et al. Among authors: caraco c. JAMA Surg. 2022 Sep 1;157(9):835-842. doi: 10.1001/jamasurg.2022.2055. JAMA Surg. 2022. PMID: 35921122
The "Great Debate" at Melanoma Bridge 2021, December 2nd-4th, 2021.
Ascierto PA, Warner AB, Blank C, Caracò C, Demaria S, Gershenwald JE, Khushalani NI, Long GV, Luke JJ, Mehnert JM, Robert C, Rutkowski P, Tawbi HA, Osman I, Puzanov I. Ascierto PA, et al. Among authors: caraco c. J Transl Med. 2022 May 10;20(1):200. doi: 10.1186/s12967-022-03406-7. J Transl Med. 2022. PMID: 35538491 Free PMC article.
Update on PEG-interferon α-2b as adjuvant therapy in melanoma.
Di Trolio R, Simeone E, Di Lorenzo G, Grimaldi AM, Romano A, Ayala F, Caracò C, Mozzillo N, Ascierto PA. Di Trolio R, et al. Among authors: caraco c. Anticancer Res. 2012 Sep;32(9):3901-9. Anticancer Res. 2012. PMID: 22993335 Review.
New paradigm for stage III melanoma: from surgery to adjuvant treatment.
Ascierto PA, Borgognoni L, Botti G, Guida M, Marchetti P, Mocellin S, Muto P, Palmieri G, Patuzzo R, Quaglino P, Stanganelli I, Caracò C. Ascierto PA, et al. Among authors: caraco c. J Transl Med. 2019 Aug 14;17(1):266. doi: 10.1186/s12967-019-2012-2. J Transl Med. 2019. PMID: 31412885 Free PMC article. Review.
173 results